Asset Appraisal

At Evaluate, our mission is simple: to help patients gain access to life-saving therapies. Evaluate is a Norstella company, a collection of prominent pharmaceutical solutions providers that have joined forces to offer a full range of consultancy services and solutions. Evaluate provides life sciences clients with the right tools and expertise to navigate complexities at each step of the drug development life cycle, from pipeline to patient. Our offerings include cutting-edge data solutions, consensus forecasts and expert advisory services alongside advanced technologies such as machine learning and predictive analytics.

Asset Appraisal is a comprehensive listing that enables the evaluation of a drug’s potential value and market performance. This listing has been designed using data from Evaluate and Citeline to support decision making on drug development, marketing strategies, and investment opportunities.

Asset appraisal is a critical evaluation process used to assess the value of various assets owned by a company. These assets can include a wide range of elements, such as research and development pipelines, manufacturing facilities, patents, trademarks, licenses, and even the value of marketed products.

The following sets of data have been included in this listing.

Historic Approvals & Launches: These tables provide information about past drug approvals and launches, which can help predict future trends and identify successful strategies.

Names and Identifiers: This data can be used to track specific drugs across different databases and sources.

Classifications: Drug classifications can provide insights into the types of drugs that are popular or successful in the market.

Product Sales: Sales data is crucial for assessing a drug’s market performance.

Profiles: Drug profiles can provide comprehensive information about a drug, including its uses, markets and dosing.

Patents: Information about patents can help assess a drug’s potential profitability.

Sales by Indication: This data can provide insights into the demand for treatments for specific conditions or diseases.

NPV (Net Present Value): NPV data can help assess the potential profitability of a drug or indication.

Events: Information about events related to a drug can provide context for its performance and potential challenges.

Predicted Approvals: Predictions about future drug approvals can inform investment and development decisions.

Trial Costs & Outcomes: Data about clinical trial costs and outcomes can help assess the feasibility and potential success of a drug.

Peak Sales: Information about a drug’s peak sales can provide insights into its market success.

European & Japan Sales: These tables provide specific regional sales data, which can inform region-specific strategies.

Drugs@FDA: Data from the FDA can provide authoritative information about a drug’s approval status and attributes.

Indication-level Treatment Information: This data provides detailed information about treatments for specific indications, which can inform development and marketing strategies for drugs targeting those indications.

In summary, these tables collectively provide a comprehensive view of a drug’s journey from development to market performance. They offer valuable insights that can inform asset appraisal in the pharmaceutical industry.

Once you subscribe to this listing, you will have access to all the data tables required.

Workflow:

• Consumer clicks Request button on Evaluate listing<br/>• Evaluate will reach out to the consumer and finalize terms.<br/>• Evaluate shares the data product with the consumer via Snowflake shares.

Additional Information<br/>This data product is updated regularly to ensure that you have the most recent and accurate information. If you have any questions or need further information, please don't hesitate to contact us.